1-5 of 5
J. Donovan
Close
Sort by
Journal Articles

A Dose Escalation Study of the Pharmacokinetics, Safety & Efficacy of Deferitrin, an Oral Iron Chelator in Beta Thalassaemia Patients.

R. Galanello, G. Forni, A. Jones, A. Kelly, A. Willemsen, X. He, A. Johnston, D. Fuller, J. Donovan, Antonio Piga
Journal: Blood
Blood (2007) 110 (11): 2669.
https://doi.org/10.1182/blood.V110.11.2669.2669
Published: 2007
Journal Articles

Daptomycin (DAP) Use in Patients with Hematologic (HEM) Cancer History; Post-Marketing Experience in a Registry.

Gorgun Akpek, MD, Graeme Forrest, MBBS, Kenneth C. Lamp, PharmD, Brian J. Donovan, PharmD, Lawrence V. Friedrich, PharmD
Journal: Blood
Blood (2005) 106 (11): 3132.
https://doi.org/10.1182/blood.V106.11.3132.3132
Published: 2005
Journal Articles

The proximal serum response element in the Egr-1 promoter mediates response to thrombin in primary human endothelial cells

Sheng-Qian Wu, Takashi Minami, Diana J. Donovan, William C. Aird
Journal: Blood
Blood (2002) 100 (13): 4454–4461.
https://doi.org/10.1182/blood-2002-02-0415
Published: 2002
Journal Articles

Differential regulation of the von Willebrand factor and Flt-1 promoters in the endothelium of hypoxanthine phosphoribosyltransferase–targeted mice

Takashi Minami, Diana J. Donovan, Jo C. Tsai, Robert D. Rosenberg, William C. Aird
Journal: Blood
Blood (2002) 100 (12): 4019–4025.
https://doi.org/10.1182/blood-2002-03-0955
Published: 2002
Journal Articles

THE EFFECT OF ARTIFICIAL SURFACES ON BLOOD COAGULABILITY, WITH SPECIAL REFERENCE TO POLYETHYLENE

THOMAS J. DONOVAN, M.D., BERNARD ZIMMERMANN, M.D.
Journal: Blood
Blood (1949) 4 (12): 1310–1316.
https://doi.org/10.1182/blood.V4.12.1310.1310
Published: 1949